SureTrader Nadex Advertisement SureTrader
Home > Boards > US Listed > Medical - Drugs >

Aralez Pharmaceuticals Inc. (ARLZ)

Add ARLZ Price Alert      Hide Sticky   Hide Intro
Moderator: Drugdoctor
Search This Board: 
Last Post: 4/26/2017 5:38:50 PM - Followers: 41 - Board type: Free - Posts Today: 0


Aralez Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada, Ireland, and the United States. It engages in acquiring, developing, and commercializing products primarily in cardiovascular disease, pain, and other specialty areas. It offers Fibricor, a fenofibric acid for the treatment of severe hypertriglyceridemia; Cambia, a non-steroidal anti-inflammatory drug (NSAID) for the acute treatment of migraine attacks; Fiorinal and Fiorinal C for the relief of tension type headaches; Soriatane, a retinoid, an aromatic analog of vitamin A for the treatment of severe psoriasis and other disorders of keratinization; and Bezalip SR, a pan-peroxisome proliferator-activated receptor activator to treat hyperlipidemia, as well as to increase insulin sensitivity and decrease blood glucose levels for the patients with metabolic syndrome. It also markets NeoVisc, a sodium hylauronic solution; Uracyst, a sodium chondroitin sulfate; Durela, a tramadol hydrochloride; Proferrin, a heme iron polypeptide; Resultz, a isopropyl myristate; Collatamp G, a collagen-gentamycin; and a portfolio of eight products targeted for the areas of gastroenterology and women?s health. In addition, it develops YOSPRALA 81/40 and 325/40 for secondary prevention of cardiovascular and cerebrovascular disease in patients at risk for gastric ulcers, which have completed Phase III clinical development in the United States; and Bilastine, an antihistamine drug for the treatment of allergic rhinoconjunctivitis and urticaria. Further, its out-licensed products include VIMOVO for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers; and Treximet, a migraine medicine. The company is headquartered in Milton, Canada.

Corporate Governance

Aralez Pharmaceuticals Inc.’s ISS Governance QualityScore as of March 2, 2017 is 6. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 4; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Aralez Pharmaceuticals Inc.

151 Steeles Avenue East
Milton, ON L9T 1Y1

Full Time Employees:

Key Executives

Name Title Pay Exercised Age
Mr. Adrian Adams Chief Exec. Officer and Director 1.02M N/A 66
Mr. Andrew I. Koven Pres and Chief Bus. Officer 683.18k N/A 59
Mr. Scott J. Charles Chief Financial Officer 653.07k N/A 42
Mr. Mark A. Glickman Chief Commercial Officer 504.94k N/A 51
Mr. John E. Barnhardt CPA Principal Accounting Officer and VP of Fin. & Admin. N/A N/A 67
Amounts are as of December 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

4th quarter 2016 EARNINGS WEBCAST and EARNINGS PDF Presentation link:

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ARLZ News: Statement of Changes in Beneficial Ownership (4) 04/25/2017 04:32:00 PM
ARLZ News: Aralez To Report First Quarter 2017 Financial Results On May 9, 2017 04/25/2017 07:00:00 AM
ARLZ News: Aralez To Report First Quarter 2017 Financial Results On May 9, 2017 04/25/2017 07:00:00 AM
ARLZ News: Current Report Filing (8-k) 04/11/2017 04:17:29 PM
ARLZ News: Aralez Announces Reduction In U.S. Sales Force And Cost Savings Program 04/05/2017 06:30:00 AM
#173   I agree, and once they become NET PROFITABLE, Drugdoctor 04/26/17 05:38:50 PM
#172   Yeah doc been adding some shares sub 1.60 island man 04/26/17 12:30:18 PM
#171   I'm adding a little here, as I think Drugdoctor 04/25/17 12:44:22 PM
#170   It appears they got the VA contract for Drugdoctor 04/12/17 01:00:39 PM
#169   The cash burn had to be slowed for Drugdoctor 04/07/17 07:52:54 AM
#168   Yes, I'd wait a few days though, the Drugdoctor 04/05/17 05:56:25 PM
#167   Might be a good time to nibble in island man 04/05/17 02:32:42 PM
#166   News out this afternoon with regards to healthcare. island man 03/24/17 02:15:52 PM
#165   Yea, I didn't hear about that, so thanks... Drugdoctor 03/22/17 12:23:23 AM
#164   Hey Doc sold yesterday for 2k profit.Bought island man 03/21/17 11:22:20 PM
#163   Yes, obviously still funds liquidating positions as they Drugdoctor 03/21/17 04:50:43 PM
#162   Just looking into this....any reason for the drop? Iron Maiden 03/21/17 03:46:48 PM
#161   We may have a gap and go today! Jess070283 03/20/17 09:02:07 AM
#160   $ARLZ - PRESS-RELEASE OUT - NEWS... Drugdoctor 03/20/17 06:44:13 AM
#159   Yeah I gathered you meant dollars and not island man 03/19/17 02:33:47 PM
#158   Yea, I feel really good about my investment Drugdoctor 03/18/17 10:47:42 PM
#157   Good you grabbed some this is a low island man 03/18/17 10:41:58 PM
#156   Yea, I grabbed a few thousand Thursday, and Drugdoctor 03/18/17 03:19:34 PM
#155   Well Well always good to see insiders buying island man 03/18/17 03:13:21 PM
#154   I will be buying more Monday... If the Drugdoctor 03/18/17 09:21:03 AM
#153   Now that's a power play. viperdeal 03/18/17 08:47:38 AM
#152   WOWSERS!-$ARLZ-2.25-CEO-bought-1.2-MILLION-DOLLARS-of-SHARES-on-OPEN MARKET![ Drugdoctor 03/18/17 04:04:07 AM
#151   If you're routinely in pharma I'd love some Winthorpe III 03/17/17 01:49:58 PM
#150   Looks well over sold, could be bottom around mentalist 03/17/17 10:52:41 AM
#149   Keep your antacids close this AM. I Winthorpe III 03/17/17 10:24:45 AM
#148   I agree, ZACK's has $6 price target... Drugdoctor 03/17/17 08:54:00 AM
#147   Picked up 20k shares between 2.30-2.35. This island man 03/16/17 09:06:02 PM
#146   ARLZ bullish 2.13 stocktrademan 03/14/17 03:43:40 PM
#145   * * $ARLZ Video Chart 03-13-17 * * ClayTrader 03/13/17 05:15:48 PM
#144   Wait for $1.75 willlbone 03/13/17 10:50:12 AM
#143   FNY Managed Accounts LLC just filed a portfolio commoncentsinvestor 02/08/17 06:59:11 PM
#142   Drill Craig A Boosts Stake in Aralez Pharmaceuticals commoncentsinvestor 01/08/17 09:27:33 PM
#141   ARLZ added to Biotechnology Index: commoncentsinvestor 12/13/16 12:45:56 PM
#140   Nice add for JW Asset djpope 12/11/16 03:58:18 PM
#139   TRADE REPORT: THE JW ASSET MANAGEMENT LLC BUYS commoncentsinvestor 12/11/16 01:49:31 AM
#138   Oneil Trader: commoncentsinvestor 11/28/16 01:01:11 PM
#137   ARLZ Director Seth Rudnick just picked up 30,000 djpope 11/15/16 07:37:58 PM
#136   And now yet another positive Seeking Alpha article commoncentsinvestor 11/15/16 07:19:58 PM
#135   Very positive Seeking Alpha article on ARLZ by commoncentsinvestor 11/15/16 03:02:57 PM
#134   Lots of new institutional buyers in Aralez - wiltonio 11/14/16 03:41:12 PM
#133   ARLZ News: Aralez To Announce Third Quarter 2016 mick 10/29/16 11:33:42 PM
#132   Aralez Pharmaceutica (ARLZ) mick 10/29/16 11:33:35 PM
#131   This is just shorts pressuring the stock & Bio_pete 10/26/16 11:01:37 PM
#130   ARLZ News: Current Report Filing (8-k) 10/07/2016 08:01:41 AM mick 10/16/16 11:35:17 PM
#129   Aralez Pharmaceutica (ARLZ) mick 10/16/16 11:35:12 PM
#128   Here are PICS of ARLZ new PRODUCTS!!! Drugdoctor 10/05/16 10:11:38 PM
#127   Congrats longs... TOPROL XL just announced bought from Drugdoctor 10/04/16 08:45:20 AM
#126   Just saw you just joined on 9/21/16 with MTH4 09/22/16 11:14:25 PM
#125   If it sounds like a dog, smells like Elkcreek60 09/21/16 11:57:40 AM
#124   so much for positivity, but 4.94 is a KantKill 09/21/16 11:26:45 AM